http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106755183-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-14 |
filingDate | 2016-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106755183-B |
titleOfInvention | A method of monosaccharide composition and ratio in regulation ganoderma lucidum exocellular polysaccharide |
abstract | The invention discloses a kind of methods of monosaccharide composition and ratio in regulation ganoderma lucidum exocellular polysaccharide, belong to field of microbial fermentation.The method of the present invention is to regulate and control the ratio of glucose, mannose and galactolipin in ganoderma lucidum exocellular polysaccharide by addition G-6-P.Realize the synthesis with the ganoderma lucidum polysaccharide of specific monosaccharide composition and ratio, there is the bioactivity for effectively inhibiting tumour cell using the ganoderma lucidum polysaccharide of this method production, inhibiting rate has for synthesis in the future and lays the foundation compared with high bioactivity, the ganoderma lucidum polysaccharide that structure is uniform, production is controllable up to 80% or more. |
priorityDate | 2016-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.